These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4096926)

  • 1. [Histological and histochemical studies of the endometrium under Ovosiston and Chlormadinon].
    Müller R; Bettzieche H
    Zentralbl Gynakol; 1970 Mar; 92(10):289-302. PubMed ID: 4096926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies on endometrial behavior under the effect of various contraceptives].
    Müller R; Bettzieche H; Kempf HJ
    Zentralbl Gynakol; 1972 Dec; 94(52):1821-9. PubMed ID: 4119793
    [No Abstract]   [Full Text] [Related]  

  • 4. Endometrial morphology after sequential medication with mestranol and chlormadinone.
    Ober WB; Decker A; Clyman MJ; Roland M
    Obstet Gynecol; 1966 Aug; 28(2):247-53. PubMed ID: 4161461
    [No Abstract]   [Full Text] [Related]  

  • 5. Endometrial study with combined 17 alpha-hydroxy progesterone contraceptives.
    Hefnawi F; Tagui AH; Askalani AH
    J Egypt Med Assoc; 1971; 54(11):814-21. PubMed ID: 4125870
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endometrium in "contraception cycle" under Ovosiston].
    Böhm W; Möbius W; Müller W
    Zentralbl Gynakol; 1969 Oct; 91(43):1412-8. PubMed ID: 4100318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of reaction times under the effect of ovosiston].
    Seewald HJ; Klinger G; Hempel E
    Zentralbl Gynakol; 1970 May; 92(22):708-11. PubMed ID: 4104819
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 9. The histopathology of the endometrium: selected topics.
    Ober SB; Labay GR
    Obstet Gynecol Annu; 1972; 1():373-420. PubMed ID: 4130219
    [No Abstract]   [Full Text] [Related]  

  • 10. [The spermatozoa penetration in vivo under ovosiston. (Results of 54 Sims-Huhner tests)].
    Kempf HJ; Müller R; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(48):1630-9. PubMed ID: 4179432
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a sequential oral contraceptive on endometrial enzyme and carbohydrate histochemistry.
    Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
    Am J Obstet Gynecol; 1968 Nov; 102(6):771-83. PubMed ID: 4176774
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of mucopolysaccharides and lysosomal hydrolases in endometrial regression following withdrawal of estradiol and chlormadinone acetate. I. Epithelium and stroma.
    Smith RE; Henzl MR
    Endocrinology; 1969 Jul; 85(1):50-66. PubMed ID: 4182327
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of contraceptive hormone preparations on the fine structure of the endometrium.
    Friedrich ER
    Obstet Gynecol; 1967 Aug; 30(2):201-19. PubMed ID: 4143586
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphology and histochemistry of the human endometrium after prolonged administration of 0.5 mg. chlormadinone acetate].
    Maqueo M; García G; Medina del Campo JJ
    Ginecol Obstet Mex; 1970 Mar; 27(161):371-5. PubMed ID: 4191764
    [No Abstract]   [Full Text] [Related]  

  • 15. Chimpanzee endometrium and sexual swelling during menstrual cycle or hormone administration.
    Graham CE
    Folia Primatol (Basel); 1973; 19(6):458-68. PubMed ID: 4129786
    [No Abstract]   [Full Text] [Related]  

  • 16. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum proteinase inhibitor capacity during administration of the oral contraceptive Ovosiston].
    Duck HJ; Ebeling K; Wagner J; Kühndel K
    Zentralbl Gynakol; 1973 Mar; 95(10):343-8. PubMed ID: 4121777
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
    Steindel E; Mohnike A; Langreck G
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):159-61. PubMed ID: 4102493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experiences in the inhibition of undesired lactation using Ovosiston].
    Kosowski I; Iliew D
    Zentralbl Gynakol; 1972 Aug; 94(34):1134-6. PubMed ID: 4116879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.